跳至主要内容
临床试验/NCT01744509
NCT01744509Unknown不适用

PillCam Colon Capsule 2® (PCC2) in the Setting of Colorectal Cancer Screening (CRC) Program: Comparison With a New Integrated Reference Standard

Valduce Hospital2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
35
试验地点
2
主要终点
Sensitivity of PillCam Colon Capsule 2 (R) in identifying significant colonic polyps

研究概览

简要总结

In this study the investigators evaluate the sensitivity of PCC2 (PillCam Colon Capsule 2 (R)) in identifying significant polyps in a CRC (Colo Recatal Cancer) screening program (primary outcome measure).

Each enrolled patient underwent three procedures: colon capsule endoscopy, CT-colonography and optical colonoscopy. In this study the reference standard is represented by the segmental unblinded colonoscopy (the unblinding is based on results of both capsule endoscopy and Ct colonography) The investigators also evaluated the tolerability of PCC2 as compared to optical colonoscopy (OC) and CT-colonography (CTC).

详细描述

Asymptomatic average risk subjects with positive iFOBT (immunochemical Fecal Occult Blood Test), participating the regional screening program, were offered to undergo PCC2 (PillCam Colon Capsule 2 (R)) followed, 21 days later, by CTC and OC performed on the same day. The number, size and location of significant polyps (>6mm) identified by each procedure were compared with the reference standard (RS), which was represented by the segmental unblinded colonoscopy. The unblinding was based on the integration of CTC and PCC2 results. For the PPC2 the quality of the bowel preparation (adequate/inadequate) and the completeness of the examination (capsule excreted still working or visualization of the anal verge) were also reported. In order to evaluate the tolerability, each subject was asked to identify, among the 3 procedures performed, which was the less tolerated one and which one he would be willing to repeat.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
50 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • asymptomatic average risk subjects, participating the regional colon cancer screening program, with positive iFOBT referred for colonoscopy

排除标准

  • presence of obstructive symptoms
  • swallowing disorders
  • presence of cardiac pacemaker

结局指标

主要结局

Sensitivity of PillCam Colon Capsule 2 (R) in identifying significant colonic polyps

时间窗: participants are followed for about 1 month

The number, size and location of significant polyps (\>6mm) identified by each procedure were compared with the reference standard (RS), which was represented by the segmental unblinded colonoscopy.

次要结局

  • to evaluate the tolerability of PCC2 as compared to optical colonoscopy (OC) and CT-colonography (CTC).(participants are followed for about 1 month)

研究者

发起方
Valduce Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Emanuele Rondonotti

MD, PhD

Valduce Hospital

研究点 (2)

Loading locations...

相似试验